sameAs
K(lysine) acetyltransferase 2BPolybromo 1Bromodomain containing 4Bromodomain containing 1Bromodomain containing 2Bromodomain containing 3Bromodomain testis associatedBromodomain containing 8Bromodomain containing 9Bromodomain containing 7SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4ASH1 like histone lysine methyltransferaseLysine methyltransferase 2ATripartite motif containing 28Bromodomain adjacent to zinc finger domain 1ABromodomain adjacent to zinc finger domain 2BBromodomain adjacent to zinc finger domain 2ABromodomain adjacent to zinc finger domain 1BZinc finger MYND-type containing 11Lysine acetyltransferase 2ABromodomain and WD repeat domain containing 3Bromodomain and WD repeat domain containing 1Bromodomain and PHD finger containing 3ATPase family AAA domain containing 2Bromodomain PHD finger transcription factorATPase family AAA domain containing 2BCECR2 histone acetyl-lysine readerBromodomain testis-specific proteinTripartite motif containing 66TATA-box binding protein associated factor 1 likeTripartite motif containing 33Tripartite motif containing 24Zinc finger MYND-type containing 8SP140 nuclear body protein likeSP110 nuclear body proteinBromodomain containing 4, isoform CRA_cBromodomain-containing protein 2Bromodomain containing 3, isoform CRA_aTranscription activator BRG1
P527
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes.Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 AcetylomeInteractome Rewiring Following Pharmacological Targeting of BET BromodomainsBET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung InflammationDeveloping BET-ter treatments for cutaneous T-cell lymphomaEGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYCHigh affinity binding of H3K14ac through collaboration of bromodomains 2, 4 and 5 is critical for the molecular and tumor suppressor functions of PBRM1Backbone and side-chain NMR assignments for the bromodomain of mouse BAZ1A (ACF1)
P921
Q32855882-753C2D22-C72B-466A-8541-78B7049FA1A6Q43921276-313065AE-432F-4407-93AB-C7216E140166Q43921353-344DABDF-A5B7-461F-9739-3509FF18BB51Q43921355-B6EBC9F6-740D-4B37-8904-6F67BFF183D0Q43921358-9A153721-E57F-4F52-B4F1-4FAB06125897Q54460565-97FD4595-67E8-4824-A994-12C205CAE62AQ54460566-D722CC94-CCC0-46D9-B513-D85AB62B8B9FQ54460567-B9B9BDFC-05D3-45EE-B7E0-563BF38859E9
P279
description
Domaine InterPro
@fr
Domínio proteico
@pt
InterPro Domain
@en
InterPro-domene
@nn
Proteindomäne
@de
chemische stof
@nl
name
Bromodomain
@en
Bromodomein
@nl
Bromodomen
@sh
Bromodomen
@sr
Bromodominio
@es
Bromodomínio
@pt
bromodomaine
@fr
bromodomene
@nn
bromodomini
@ca
Бромодомен
@mk
type
label
Bromodomain
@en
Bromodomein
@nl
Bromodomen
@sh
Bromodomen
@sr
Bromodominio
@es
Bromodomínio
@pt
bromodomaine
@fr
bromodomene
@nn
bromodomini
@ca
Бромодомен
@mk
altLabel
IPR001487
@en
prefLabel
Bromodomain
@en
Bromodomein
@nl
Bromodomen
@sh
Bromodomen
@sr
Bromodominio
@es
Bromodomínio
@pt
bromodomaine
@fr
bromodomene
@nn
bromodomini
@ca
Бромодомен
@mk